No Neuron Operates in Isolation
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Medical students are taught that an exacting neurologic examination is the cornerstone of neurology and permits lesion localization in the nervous system. This is certainly the case for bitemporal hemianopsia, with lesions of the optic chiasm and discreet sensorimotor deficits with compressive neuropathies in the peripheral nervous system. In the CNS, classically and most commonly, the tetrad of dyscalculia, dysgraphia, finger agnosia, and left-right disorientation (Gerstmann syndrome) is associated with damage to the angular and supramarginal gyri of the dominant hemisphere. Also classically, but often incorrectly, involuntary movements such as dystonia, tremor, chorea, ballism, athetosis, dyskinesia, and tics are linked to dysfunction of the basal ganglia. In this issue of Neurology®, Ekmen et al.1 used voxel-based morphometry, fixel-based analysis, and spectral dynamic causal modeling in a well-defined cohort of patients with paroxysmal kinesigenic dyskinesias (PKD) due to mutations in PRRT2 to provide rigorous support for the concept that abnormal cerebellar output can drive dystonia. Dystonia was the sole involuntary movement in this PKD cohort. Patients with PRRT2 had decreased gray matter volume in cerebellar lobule V and medial prefrontal cortex, as well as microstructural alterations of white matter in the cerebellum and tracts connecting the cerebellum to the striatum and cortical motor areas. On the basis of these structural findings in combination with the results of transcranial magnetic stimulation of the cerebellum and spectral dynamic causal modeling, the authors propose that striatal dysfunction in PKD results from upstream abnormalities of cerebellar signaling.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 400
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Association of Neurofilament Light With the Development and Severity of Parkinson Disease
Dr. Rodolfo Savica and Dr. Parichita Choudhury